Stockholders’ Deficit (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Equity [Abstract] |
|
| Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements |
The
following table summarizes stock-based compensation expense recognized for all officer and director arrangements for the three months
ended March 31, 2026 and 2025:
Schedule
of Stock Based Compensation Expense Recognized for Officer and Director Arrangements
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Chief Financial Officer | |
$ | - | | |
$ | 119,770 | |
| Board of Directors | |
| 49,895 | | |
| 35,349 | |
| Total | |
$ | 49,895 | | |
$ | 155,119 | |
| Stock based compensation
expense | |
$ | 49,895 | | |
$ | 155,119 | |
|
| Schedule of Non-vested Shares Related Parties |
The
following is a summary of the Company’s non-vested shares at March 31, 2026 and December 31, 2025.
Schedule
of Non-vested Shares Related Parties
| | |
| | |
Weighted Average | |
| Non-Vested Shares | |
Number of Shares | | |
Grant Date Fair Value | |
| Balance - December 31, 2024 | |
| 139,640 | | |
$ | 5.03 | |
| Granted | |
| 150,000 | | |
| 3.16 | |
| Vested | |
| (88,880 | ) | |
| 4.77 | |
| Cancelled/Forfeited | |
| - | | |
| - | |
| Balance - December 31, 2025 | |
| 200,760 | | |
| 4.00 | |
| Granted | |
| - | | |
| | |
| Vested | |
| - | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| | |
| Balance - March 31, 2026 | |
| 200,760 | | |
$ | 4.00 | |
| | |
| | | |
| | |
| Unrecognized Compensation | |
$ | 457,367 | | |
| | |
| | |
| | | |
| | |
| Weighted average period (years) | |
| 2.33 | | |
| | |
|
| Schedule of Stock Option Transactions |
Stock
option transactions for the three months ended March 31, 2026 and the year ended December 31, 2025 are summarized as follows:
Schedule
of Stock Option Transactions
| | |
| | |
| | |
Weighted | | |
| | |
Weighted | |
| | |
| | |
Weighted | | |
Average | | |
| | |
Average | |
| | |
| | |
Average | | |
Remaining | | |
Aggregate | | |
Grant | |
| | |
Number of | | |
Exercise | | |
Contractual | | |
Intrinsic | | |
Date | |
| Stock Options | |
Options | | |
Price | | |
Term (Years) | | |
Value | | |
Fair Value | |
| Outstanding - December 31, 2024 | |
| 1,166,081 | | |
$ | 2.37 | | |
| 6.85 | | |
$ | - | | |
| | |
| Vested and Exercisable - December 31, 2024 | |
| 1,166,081 | | |
$ | 2.37 | | |
| 6.85 | | |
$ | - | | |
| | |
| Granted | |
| 1,144,116 | | |
$ | 1.75 | | |
| | | |
| | | |
$ | 1.49 | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| (17,253 | ) | |
$ | 1.78 | | |
| | | |
| | | |
| | |
| Outstanding - December 31, 2025 | |
| 2,292,944 | | |
$ | 2.06 | | |
| 6.43 | | |
$ | - | | |
| | |
| Vested and Exercisable - December 31, 2025 | |
| 2,292,944 | | |
$ | 2.06 | | |
| 6.43 | | |
$ | - | | |
| | |
| Granted | |
| - | | |
$ | - | | |
| | | |
| | | |
$ | - | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| (324,750 | ) | |
$ | 2.51 | | |
| | | |
| | | |
| | |
| Outstanding - March 31, 2026 | |
| 1,968,194 | | |
$ | 1.99 | | |
| 6.22 | | |
$ | - | | |
| | |
| Vested and Exercisable - March 31, 2026 | |
| 1,968,194 | | |
$ | 1.99 | | |
| 6.22 | | |
$ | - | | |
| | |
|
| Schedule of Fair Value of Stock Options |
The
fair value of these stock options was determined using the Black-Scholes option pricing model with the following inputs:
Schedule of Fair Value of Stock Options
| Expected term | |
| 7 years | |
| Expected volatility | |
| 103 | % |
| Expected dividends | |
| 0 | % |
| Risk free interest rate | |
| 3.88 | % |
|
| Schedule of Stock Based Compensation Expense |
Stock-based
compensation expense related to stock options for the three months ended March 31, 2026 and 2025, was as follows:
Schedule of Stock Based Compensation Expense
| | Three Months Ended March 31, |
| | 2026 | | |
| 2025 | |
| $ | - | | |
$ | - | |
|
| Schedule of Warrants Activity |
Warrant
activity for the three months ended March 31, 2026 and the year ended December 31, 2025 are summarized as follows:
Schedule
of Warrants Activity
| | |
| | |
| | |
Weighted | | |
| |
| | |
| | |
| | |
Average | | |
| |
| | |
| | |
Weighted | | |
Remaining | | |
Aggregate | |
| | |
Number of | | |
Average | | |
Contractual | | |
Intrinsic | |
| Warrants | |
Warrants | | |
Exercise Price | | |
Term (Years) | | |
Value | |
| Outstanding - December 31, 2024 | |
| 96,000 | | |
$ | 4.73 | | |
| 0.37 | | |
$ | - | |
| Vested and Exercisable - December 31, 2024 | |
| 96,000 | | |
$ | 4.73 | | |
| 0.37 | | |
$ | - | |
| Granted | |
| 730,000 | | |
$ | 5.86 | | |
| | | |
| | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | |
| Cancelled/Forfeited | |
| (96,000 | ) | |
$ | 4.73 | | |
| | | |
| | |
| Outstanding - December 31, 2025 | |
| 730,000 | | |
$ | 5.86 | | |
| 4.30 | | |
$ | - | |
| Vested and Exercisable - December 31, 2025 | |
| 730,000 | | |
$ | 5.86 | | |
| 4.30 | | |
$ | - | |
| Granted | |
| 435,000 | | |
$ | 1.27 | | |
| | | |
| | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
$ | - | | |
| | | |
| | |
| Outstanding - March 31, 2026 | |
| 1,165,000 | | |
$ | 4.14 | | |
| 4.38 | | |
$ | - | |
| Vested and Exercisable - March 31, 2026 | |
| 1,165,000 | | |
$ | 4.14 | | |
| 4.38 | | |
$ | - | |
|